For patients currently managing costs through compounding pharmacies that provide peptide-based GLP-1 analogs, such as compounded semaglutide available through FormBlends, the entry of an affordable oral option will provide an additional choice
In addition, the latest guidelines classify microglial states into five major phenotypes: homeostatic, DAM-like, HLA/MHC class II, CRM or inflammatory, and interferon (IRM or IFN) clusters [105]
Point of care ultrasonography can be used to assess risks in patients who do not follow dietary restrictions and in patients who describe gastrointestinal symptoms on the day of the procedure
Mild pruritus or localized erythema may require only reassurance
Patients should be counseled to recognize signs of allergic responses, including widespread rash, hives, facial swelling, or difficulty breathing, which require immediate medical attention
Dual GIP/GLP-1 Receptor Agonists Tirzepatide (Mounjaro) For Type 2 Diabetes Mounjaros May 13, 2022 approval introduced dual GIP/GLP 1 receptor agonism to type 2 diabetes treatment
